7th Annual USC Multi-Disciplinary Breast Cancer Symposium

 

Videos
11:12

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

The Role of CDK4/6 in HR+ BC: 2nd, 3rd Line and Beyond, and Single-agent Abemaciclib, and Discussion of Toxicity Profiles

FEATURING Gabriel Hortobagyi
  • 58 views
  • January 22, 2021
23:16

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Progress in Management of HR+ BC

FEATURING Gabriel Hortobagyi
  • 80 views
  • May 27, 2020
13:23

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Combined Inhibition of Endocrine Therapy and the PI3K/AKT/mTOR Pathways Appears Superior to Either Component in HR+ Metastatic Breast Cancer

FEATURING Gabriel Hortobagyi
  • 279 views
  • May 27, 2020
  • 1
28:05

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

2019 SABCS Update on HER2 Directed Breast Cancer Therapies: Monoclonal Antibodies, TKIs, Immunoconjugates

FEATURING Charles Geyer
  • 441 views
  • February 25, 2020
  • 1
13:46

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

New Data Show Pertuzumab + Trastuzumab + Chemo Continue Yielding Clinical Benefit / Adjuvant T-DM1 Benefit in HER2+ Early BC

FEATURING Charles Geyer
  • 1,187 views
  • February 25, 2020
  • 4
17:08

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

2020 Update on IO for Metastatic Breast Cancer: Atezolizumab Approval + Selected Ongoing Trials

FEATURING Jennifer Litton
  • 1,245 views
  • February 25, 2020
  • 9
15:26

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

2020 Update on (Neo)adjuvant IO for Early Breast Cancer: Should We Be Exposing All of Our Early TNBC Patients to IO?

FEATURING Jennifer Litton
  • 77 views
  • February 25, 2020
31:25

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Emerging Tools in Breast Imaging: Tomosynthesis and Contrast Enhanced Mammography

FEATURING Mary Yamashita
  • 697 views
  • February 25, 2020
  • 7
08:47

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Advances in Axillary Surgery in Breast-Conserving Therapy and Mastectomy

FEATURING Judy Boughey
  • 67 views
  • February 25, 2020
12:14

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Patients Who Can Avoid Axillary Surgery: Women Age 70+ With HR+ Disease

FEATURING Judy Boughey
  • 377 views
  • February 25, 2020
  • 4
20:13

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Axillary Surgery in Neoadjuvant Chemotherapy in Breast Cancer

FEATURING Judy Boughey
  • 152 views
  • February 25, 2020
  • 2
35:39

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Dose De-Escalation Strategies in Radiation Therapy for BC: Minimally Higher LR vs. WBRT, but the Difference Is Likely Not Clinically Significant for the Most

FEATURING Jason Ye
  • 142 views
  • February 25, 2020
  • 1
30:18

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Fertility Preservation and Breast Cancer: Chemo Causes Oocyte Loss, Adjuvant Therapy Causes Delay in Childbearing, Both Affecting Future Fertility

FEATURING Jacqueline Ho
  • 35 views
  • February 25, 2020
10:34

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Postmastectomy Radiation in High-risk Breast Cancer Patients Decreases Locoregional Recurrence and Increases OS

FEATURING Stephen Sener
  • 52 views
  • February 25, 2020
12:00

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Why We SHOULD Do Immediate Reconstruction in Most Breast Cancer Patients?

FEATURING Ketan Patel
  • 53 views
  • February 25, 2020
15:26

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

The Optimal Timing and Modality for Breast Reconstruction in Patients Requiring PMRT

FEATURING Jason Ye
  • 31 views
  • February 25, 2020
21:57

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

46 y/o Female w/Bilateral Breast Cancer: Lymph Node Localization and (Neo)adjuvant Disease Management

FEATURING Crystal Fancher
  • 24 views
  • February 25, 2020
12:30

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Treatment and Next Steps for Case of 38 y/o Female With Metastatic ER/PR+, HER2- Breast Cancer After CDK4/6 Inhibition

FEATURING Priya Jayachandran
  • 130 views
  • February 25, 2020
  • 1
18:59

7th Annual USC Multi-Disciplinary Breast Cancer Symposium

Treatment of 52 y/o Women With Inflammatory Breast Cancer - What Is the Best Treatment Option for Invasive Ductal Carcinomas? What Is Prognosis After Neoadjuvant Treatment?

FEATURING Christin Collins
  • 91 views
  • February 28, 2020
  • 1